PARSCHAUER KARAH HERDMAN (EVP and Chief Legal Officer) sold 9.6% of their position (8.13K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $185.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001193125-26-089111
Officer· EVP and Chief Legal Officer
Since Mar 2026
+3K
Net shares
Net buyer
$185.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.14K acquired · 8.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.14K
Price / share
—
Trade value
—
% of position
15.2%
3/1/2026
73.27K→84.41K
Common Stock
Direct
Shares
−8.13K
Price / share
$22.80
Trade value
$185.48K
% of position
9.6%
3/2/2026
84.48K→76.35K
Total
Net shares
+3K
Net value
-$185.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +11.14K | — | — | 15.2% | 73.27K | 84.41K |
| Common Stock Direct | 3/2/2026 | S · Sale | −8.13K | $22.80 | $185.48K | 9.6% | 84.48K | 76.35K |
| Total | +3K | -$185.48K | ||||||
Derivative Transactions0
No derivative transactions reported